Investors Purchase Large Volume of Put Options on SPDR S&P Biotech (XBI)

SPDR S&P Biotech (NYSEARCA:XBI) was the target of some unusual options trading activity on Monday. Stock traders acquired 38,551 put options on the stock. This is an increase of 319% compared to the typical volume of 9,208 put options.

Shares of SPDR S&P Biotech (NYSEARCA:XBI) traded down 0.99% on Friday, reaching $69.31. The company’s stock had a trading volume of 1,901,321 shares. The firm’s 50-day moving average price is $69.16 and its 200-day moving average price is $66.01. SPDR S&P Biotech has a 12 month low of $49.34 and a 12 month high of $72.58.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this news story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright law. The correct version of this news story can be accessed at https://www.chaffeybreeze.com/2017/05/19/stock-traders-buy-high-volume-of-put-options-on-spdr-sp-biotech-xbi-updated-updated-updated.html.

About SPDR S&P Biotech

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Receive News & Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply